Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1–3 clinical trials: A Children’s Cancer and Leukaemia Group (CCLG) study-Reference-Cited by-同舟云学术

Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1–3 clinical trials: A Children’s Cancer and Leukaemia Group (CCLG) study

Published:2009-03 Issue:5 Volume:45 Page:819-826
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Messahel Boo,Williams Richard,Ridolfi Antonia,A’Hern Roger,Warren William,Tinworth Lorna,Hobson Rachel,Al-Saadi Reem,Whyman Gavin,Brundler Marie-Anne,Kelsey Anna,Sebire Neil,Jones Chris,Vujanic Gordan,Pritchard-Jones Kathy

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. The treatment of stages I–IV favorable histology Wilms’ tumor;Green;J Clin Oncol,2004

2. The genetics of Wilms tumour – a case of disrupted development;Hastie;Ann Rev Genet,1994

3. Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parameters;Klamt;Genes Chromosomes Cancer,1998

4. Loss of heterozygosity for chromosomes 16q and 1p in Wilms’ tumors predicts an adverse outcome;Grundy;Cancer Res,1994

5. Loss of heterozygosity on chromosome 16 in sporadic Wilms’ tumour;Grundy;Brit J Cancer,1998

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of heterozygosity for chromosomes 16q in Wilms tumors predicts outcomes: A meta-analysis;World Journal of Gastrointestinal Oncology;2024-05-15

2. Expertise Area 3.5: Rare renal tumour surgery;Rare and Complex Urology;2024

3. Hallmark discoveries in the biology of Wilms tumour;Nature Reviews Urology;2023-10-17

4. Biomarkers for patients with Wilms tumor: a review;Frontiers in Oncology;2023-07-24

5. Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature;Cancers;2021-06-23